Stockreport

Relmada Therapeutics, Inc. (RLMD) Q2 2024 Earnings Call Transcript [Seeking Alpha]

Relmada Therapeutics, Inc.  (RLMD) 
NASDAQ:AMEX Investor Relations: ir.relmada.com
PDF Follow Q2: 2024-08-07 Earnings Summary Play Call Press Release 10-Q EPS of -$0.59 beats by $0.24 | Revenue of beats by $0.00 Relmada Therapeutics, Inc. ( NA [Read more]